The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer

Nature Cell Biology

Volumn 18, Issue 2, 2016, Pages 213-224

  Lin, Aifu ^a   Li, Chunlai ^a   Xing, Zhen ^a   Hu, Qingsong ^a   Liang, Ke ^a   Han, Leng ^b   Wang, Cheng ^c   Hawke, David H ^a   Wang, Shouyu ^a   Zhang, Yanyan ^a   Wei, Yongkun ^a   Ma, Guolin ^d   Park, Peter K ^a   Zhou, Jianwei ^c   Zhou, Yan ^e   Hu, Zhibin ^c   Zhou, Yubin ^d   Marks, Jeffery R ^f   Liang, Han ^a   Hung, Mien Chie ^a,g,h   Lin, Chunru ^a,g   Yang, Liuqing ^a,g   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c NANJING MEDICAL UNIVERSITY   (China)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^e YIXING PEOPLE S HOSPITAL   (China)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF TEXAS   (United States)

^h CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR KINASE; E1A ASSOCIATED P300 PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LEUCINE RICH REPEAT KINASE 2; LONG INTERGENIC NON CODING RNA FOR KINASE ACTIVATION; LONG UNTRANSLATED RNA; PROTEIN KINASE; UNCLASSIFIED DRUG; EGFR PROTEIN, HUMAN; EP300 PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; GPNMB PROTEIN, HUMAN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HIF1A PROTEIN, HUMAN; LINK-A LONG NON-CODING RNA, HUMAN; LRRK2 PROTEIN, HUMAN; MEMBRANE PROTEIN; MULTIPROTEIN COMPLEX; PROLINE; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; PTK6 PROTEIN, HUMAN; SERINE; TUMOR PROTEIN; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; FEMALE; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROXYLATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER; ANIMAL; CYTOPLASM; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; PHOSPHORYLATION; PROGNOSIS; RNA INTERFERENCE; TIME FACTOR; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CYTOPLASM; E1A-ASSOCIATED P300 PROTEIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOLYSIS; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; HUMANS; HYDROXYLATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LEUCINE-RICH REPEAT SERINE-THREONINE PROTEIN KINASE-2; MEMBRANE GLYCOPROTEINS; MICE, NUDE; MULTIPROTEIN COMPLEXES; NEOPLASM PROTEINS; PHOSPHORYLATION; PROGNOSIS; PROLINE; PROTEIN STABILITY; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; RNA, LONG NONCODING; SERINE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRIPLE NEGATIVE BREAST NEOPLASMS; TYROSINE;

EID: 84956834612     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb3295     Document Type: Article

References (62)

1. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
2. Foulkes, W. D., Smith, I. E. & Reis-Filho, J. S. Triple-negative breast cancer. N. Engl. J. Med. 363, 1938-1948 (2010).
3. Hudis, C. A. & Gianni, L. Triple-negative breast cancer: an unmet medical need. Oncologist 16, 1-11 (2011).
4. Prensner, J. R. & Chinnaiyan, A. M. The emergence of lncRNAs in cancer biology. Cancer Discov. 1, 391-407 (2011).
5. Cheetham, S. W., Gruhl, F., Mattick, J. S. & Dinger, M. E. Long noncoding RNAs and the genetics of cancer. Br. J. Cancer 108, 2419-2425 (2013).
6. Gutschner, T. & Diederichs, S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 9, 703-719 (2012).
7. Lee, J. T. Epigenetic regulation by long noncoding RNAs. Science 338, 1435-1439 (2012).
8. Rinn, J. L. & Chang, H. Y. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 81, 145-166 (2012).
9. Batista, P. J. & Chang, H. Y. Long noncoding RNAs: cellular address codes in development and disease. Cell 152, 1298-1307 (2013).
10. Morlando, M., Ballarino, M., Fatica, A. & Bozzoni, I. The role of long noncoding RNAs in the epigenetic control of gene expression. ChemMedChem 9, 505-510 (2014).
11. Orom, U. A., Derrien, T., Guigo, R. & Shiekhattar, R. Long noncoding RNAs as enhancers of gene expression. Cold Spring Harb. Symp. Quant. Biol. 75, 325-331 (2010).
12. Ponting, C. P., Oliver, P. L. & Reik, W. Evolution and functions of long noncoding RNAs. Cell 136, 629-641 (2009).
13. Vance, K. W. & Ponting, C. P. Transcriptional regulatory functions of nuclear long noncoding RNAs. Trends Genet. 30, 348-355 (2014).
14. Wang, X., Song, X., Glass, C. K. & Rosenfeld, M. G. The long arm of long noncoding RNAs: roles as sensors regulating gene transcriptional programs. Cold Spring Harb. Perspect. Biol. 3, a003756 (2011).
15. Yang, L. et al. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature 500, 598-602 (2013).
16. Xing, Z. et al. lncRNA directs cooperative epigenetic regulation downstream of chemokine signals. Cell 159, 1110-1125 (2014).
17. Yuan, J. H. et al. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 25, 666-681 (2014).
18. Prensner, J. R. et al. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat. Genet. 45, 1392-1398 (2013).
19. Trimarchi, T. et al. Genome-wide mapping and characterization of notch-regulated long noncoding RNAs in acute leukemia. Cell 158, 593-606 (2014).
20. Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076 (2010).
21. Mercer, T. R. & Mattick, J. S. Structure and function of long noncoding RNAs in epigenetic regulation. Nat. Struct. Mol. Biol. 20, 300-307 (2013).
22. Carrieri, C. et al. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature 491, 454-457 (2012).
23. Wang, P. et al. The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation. Science 344, 310-313 (2014).
24. Yoon, J. H., Abdelmohsen, K. & Gorospe, M. Posttranscriptional gene regulation by long noncoding RNA. J. Mol. Biol. 425, 3723-3730 (2013).
25. Castello, A. et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 149, 1393-1406 (2012).
26. Ciesla, J. Metabolic enzymes that bind RNA: yet another level of cellular regulatory network? Acta Biochim. Pol. 53, 11-32 (2006).
27. Lunde, B. M., Moore, C. & Varani, G. RNA-binding proteins: modular design for efficient function. Nat. Rev. Mol. Cell Biol. 8, 479-490 (2007).
28. Semenza, G. L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732 (2003).
29. Denko, N. C. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer 8, 705-713 (2008).
30. Wong, C. C. et al. Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation. Proc. Natl Acad. Sci. USA 108, 16369-16374 (2011).
31. 2 sensing. Science 292, 464-468 (2001).
32. Min, J. H. et al. Structure of an HIF-1α-pVHL complex: hydroxyproline recognition in signaling. Science 296, 1886-1889 (2002).
33. Knowles, H. J., Mole, D. R., Ratcliffe, P. J. & Harris, A. L. Normoxic stabilization of hypoxia-inducible factor-1α by modulation of the labile iron pool in differentiating U937 macrophages: effect of natural resistance-associated macrophage protein 1. Cancer Res. 66, 2600-2607 (2006).
34. Kuschel, A., Simon, P. & Tug, S. Functional regulation of HIF-1α under normoxia - is there more than post-translational regulation? J. Cell. Physiol. 227, 514-524 (2012).
35. Livasy, C. A. et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod. Pathol. 19, 264-271 (2006).
36. Badve, S. et al. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod. Pathol. 24, 157-167 (2011).
37. Bubb, K. L. et al. Scan of human genome reveals no new loci under ancient balancing selection. Genetics 173, 2165-2177 (2006).
38. Regan Anderson, T. M. et al. Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression. Cancer Res. 73, 5810-5820 (2013).
39. Miah, S., Martin, A. & Lukong, K. E. Constitutive activation of breast tumor kinase accelerates cell migration and tumor growth in vivo. Oncogenesis 1, e11 (2012).
40. Agalliu, I. et al. Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis. JAMA Neurol. 72, 58-65 (2015).
41. Martin, I. et al. Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease. Cell 157, 472-485 (2014).
42. Rose, A. A. et al. Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer. Clin. Cancer Res. 16, 2147-2156 (2010).
43. Ueno, N. T. & Zhang, D. Targeting EGFR in triple negative breast cancer. J. Cancer 2, 324-328 (2011).
44. 1 for efficient breast cancer metastasis. Oncogene 34, 5494-5504 (2015).
45. Saito, Y., Haendeler, J., Hojo, Y., Yamamoto, K. & Berk, B. C. Receptor heterodimerization: essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation. Mol. Cell. Biol. 21, 6387-6394 (2001).
46. Qiu, H. & Miller, W. T. Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition. J. Biol. Chem. 277, 34634-34641 (2002).
47. Kamalati, T. et al. Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor. J. Biol. Chem. 271, 30956-30963 (1996).
48. Brauer, P. M. & Tyner, A. L. Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK. Biochim. Biophys. Acta 1806, 66-73 (2010).
49. Mahon, P. C., Hirota, K. & Semenza, G. L. FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15, 2675-2686 (2001).
50. Andrews, S. J. & Rothnagel, J. A. Emerging evidence for functional peptides encoded by short open reading frames. Nat. Rev. Genet. 15, 193-204 (2014).
51. Ruiz-Orera, J., Messeguer, X., Subirana, J. A. & Alba, M. M. Long non-coding RNAs as a source of new peptides. eLife 3, e03523 (2014).
52. Anderson, D. M. et al. A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell 160, 595-606 (2015).
53. Stroka, D. M. et al. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J. 15, 2445-2453 (2001).
54. Schwab, L. P. et al. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer. Breast Cancer Res. 14, R6 (2012).
55. Yu, X., Sharma, K. D., Takahashi, T., Iwamoto, R. & Mekada, E. Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling. Mol. Biol. Cell 13, 2547-2557 (2002).
56. Wang, K. et al. MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res. 38, e178 (2010).
57. Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621-628 (2008).
58. Han, L. et al. The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes. Nat. Commun. 5, 3963 (2014).
59. Borowicz, S. et al. The soft agar colony formation assay. J. Vis. Exp. 92, e51998 (2014).
60. Ortiz-Barahona, A., Villar, D., Pescador, N., Amigo, J. & del Peso, L. Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction. Nucleic Acids Res. 38, 2332-2345 (2010).
61. Schodel, J. et al. High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 117, e207-e217 (2011).
62. Benita, Y. et al. An integrative genomics approach identifies hypoxia inducible factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res. 37, 4587-4602 (2009).